Designed to transform the treatment landscape for diabetes, metabolic syndrome and weight loss, Laxxon's breakthrough oral GLP-1 agonist, LXM.2, offers a once-daily robust alternative to injections ...
BendPak has built a reputation for listening to our customers and developing innovative products they can count on to keep them safe, comfortable, and efficient at work and at play,” says Jeff Kritzer ...